GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (OTCPK:GLAXF) » Definitions » Cyclically Adjusted PB Ratio

GSK (GLAXF) Cyclically Adjusted PB Ratio : 6.78 (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2024-04-28), GSK's current share price is $19.852. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $2.93. GSK's Cyclically Adjusted PB Ratio for today is 6.78.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

GLAXF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.88   Med: 8.05   Max: 12
Current: 7.19

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.88. And the median was 8.05.

GLAXF's Cyclically Adjusted PB Ratio is ranked worse than
90.88% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs GLAXF: 7.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Dec. 2023 was $4.165. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.93 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.57 8.29 8.76 6.76 6.31

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 6.59 6.21 6.55 6.31

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.



GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=19.852/2.93
=6.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.165/130.0000*130.0000
=4.165

Current CPI (Dec. 2023) = 130.0000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201403 2.854 99.300 3.736
201406 2.694 99.800 3.509
201409 2.117 100.000 2.752
201412 1.715 99.900 2.232
201503 2.855 99.600 3.726
201506 2.729 100.100 3.544
201509 2.153 100.200 2.793
201512 1.965 100.400 2.544
201603 1.027 100.400 1.330
201606 0.209 101.000 0.269
201609 0.046 101.500 0.059
201612 0.357 102.200 0.454
201703 0.541 102.700 0.685
201706 0.264 103.500 0.332
201709 0.441 104.300 0.550
201712 -0.023 105.000 -0.028
201803 -0.025 105.100 -0.031
201806 1.233 105.900 1.514
201809 1.487 106.600 1.813
201812 1.205 107.100 1.463
201903 1.337 107.000 1.624
201906 1.148 107.900 1.383
201909 3.651 108.400 4.379
201912 3.745 108.500 4.487
202003 4.071 108.600 4.873
202006 4.238 108.800 5.064
202009 4.610 109.200 5.488
202012 4.872 109.400 5.789
202103 5.123 109.700 6.071
202106 5.358 111.400 6.253
202109 5.264 112.400 6.088
202112 4.973 114.700 5.636
202203 5.298 116.500 5.912
202206 4.958 120.500 5.349
202209 2.548 122.300 2.708
202212 3.153 125.300 3.271
202303 3.540 126.800 3.629
202306 3.913 129.400 3.931
202309 4.007 130.100 4.004
202312 4.165 130.000 4.165

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (OTCPK:GLAXF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (GLAXF) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.